Thalassaemia gene therapy: NICE approves Nobel Prize-winning CRISPR technology for NHS use
Hundreds of NHS England (NHSE) patients are set to benefit from access to the first gene therapy in Europe for...
Hundreds of NHS England (NHSE) patients are set to benefit from access to the first gene therapy in Europe for...
In late 2023, the Medicines and Healthcare products Regulatory Agency approved Vertex’s Casgevy, which became the inaugural clustered regularly interspaced...
SOTI’s study surveyed 1,450 healthcare IT decision-makers globally, with 150 respondents from Canada. Conducted between March 7 and March 25,...
These exciting players could deliver explosive growth over time. Cathie Wood's success is based on two main things: finding innovators...
Company LogoGlobal CRISPR MarketGlobal CRISPR MarketDublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "Global CRISPR Market by Product (Enzymes, Kits,...
Recent advancements in genome editing technology have opened up new avenues in the fight against cancer. One such promising technology...
If you had to bet on two “big picture” sectors to invest in for the long haul, you can’t go...
Images via NIH /Flickr; Shutterstock. This article was originally published in June 2018 and has since been updated to reflect...
Changchun Liu, professor of Biomedical Engineering at UConn Health, has developed a new method that improves existing diagnostic technology for...